Emcure Pharmaceuticals Limited
Equibles does not estimate personal net worth.
Piyush Nahar has spoken on 2 earnings calls across 1 company, most recently for Emcure Pharmaceuticals Limited on November 3, 2026. Emcure Pharmaceuticals Limited is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“So, we don't break out by product, but as I think Saripha had mentioned in his readout, Ampo is one of the growth drivers. It's a key growth driver for Europe growth, but it's not the only one.”
“I think they will continue to be big hitters, you know, that will contribute and continue to be in momentum with the Stanford, some of the other filings that... We are expecting approval for shortly.”
Emcure Pharmaceuticals Limited
Transcript header (unverified)
Emcure Pharmaceuticals Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call for the Quarter Ended September 30, 2026
Emcure Pharmaceuticals Limited
Earnings Call
Emcure Pharmaceuticals Limited
